Alison Cooper

3.8k total citations · 1 hit paper
61 papers, 2.7k citations indexed

About

Alison Cooper is a scholar working on Cellular and Molecular Neuroscience, Neurology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Alison Cooper has authored 61 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cellular and Molecular Neuroscience, 14 papers in Neurology and 11 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Alison Cooper's work include Neuroscience and Neuropharmacology Research (15 papers), Neurological disorders and treatments (11 papers) and Parkinson's Disease Mechanisms and Treatments (9 papers). Alison Cooper is often cited by papers focused on Neuroscience and Neuropharmacology Research (15 papers), Neurological disorders and treatments (11 papers) and Parkinson's Disease Mechanisms and Treatments (9 papers). Alison Cooper collaborates with scholars based in United Kingdom, United States and India. Alison Cooper's co-authors include Ian M. Stanford, Bruce S. Kristal, Ian Mitchell, Mark Griffiths, Kate Grimshaw, Emily B. Prince, Donna McCann, John O. Warner, Elizabeth Kitchin and Kris Yuet Wan Lok and has published in prestigious journals such as The Lancet, Journal of Neuroscience and The Journal of Physiology.

In The Last Decade

Alison Cooper

58 papers receiving 2.6k citations

Hit Papers

Food additives and hyperactive behaviour in 3-year-old an... 2007 2026 2013 2019 2007 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alison Cooper United Kingdom 22 897 550 458 343 316 61 2.7k
Luigi X. Cubeddu United States 37 1.1k 1.2× 129 0.2× 1.1k 2.4× 230 0.7× 99 0.3× 146 3.9k
Sophie Sarre Belgium 38 1.6k 1.8× 809 1.5× 1.2k 2.6× 72 0.2× 218 0.7× 118 4.6k
James G. Flood United States 27 481 0.5× 110 0.2× 365 0.8× 130 0.4× 87 0.3× 73 2.5k
Diana G. Wilkins United States 38 1.4k 1.6× 143 0.3× 783 1.7× 133 0.4× 115 0.4× 111 4.3k
C. J. Peter Eriksson Finland 37 988 1.1× 271 0.5× 1.1k 2.3× 280 0.8× 32 0.1× 126 4.6k
Marilise Escobar Bürger Brazil 33 560 0.6× 184 0.3× 511 1.1× 603 1.8× 52 0.2× 150 3.3k
Marko Lehtonen Finland 32 442 0.5× 148 0.3× 1.8k 3.9× 215 0.6× 79 0.3× 151 4.0k
Karl Engelman United States 37 420 0.5× 272 0.5× 550 1.2× 881 2.6× 56 0.2× 69 3.8k
Jean‐Luc Daval France 32 800 0.9× 179 0.3× 1.1k 2.4× 225 0.7× 27 0.1× 86 3.7k
Björn Lemmer Germany 38 467 0.5× 79 0.1× 1.0k 2.2× 317 0.9× 201 0.6× 183 5.1k

Countries citing papers authored by Alison Cooper

Since Specialization
Citations

This map shows the geographic impact of Alison Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Cooper more than expected).

Fields of papers citing papers by Alison Cooper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Cooper. The network helps show where Alison Cooper may publish in the future.

Co-authorship network of co-authors of Alison Cooper

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Cooper. A scholar is included among the top collaborators of Alison Cooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Cooper. Alison Cooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
England, Clare, Nathan Bromham, Juliet Hounsome, et al.. (2025). Complications and costs to the NHS due to outward medical tourism for elective surgery: a rapid review. medRxiv.
2.
Bull, Stephanie, et al.. (2024). ‘You certainly don’t get promoted for just teaching’: experiences of education-focused academics in research-intensive universities. Studies in Higher Education. 50(2). 239–255. 11 indexed citations
4.
Cooper, Alison, et al.. (2023). An Evaluation of Contingent Gum Chewing on Rumination Exhibited by an Adolescent with Autism Spectrum Disorder. Behavior Analysis in Practice. 16(4). 1211–1215. 1 indexed citations
5.
Roberts, A, Gillian Grafton, Andrew D. Powell, et al.. (2020). CSTI-300 (SMP-100); a Novel 5-HT3 Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid Syndrome. Journal of Pharmacology and Experimental Therapeutics. 373(1). 122–134. 7 indexed citations
6.
McCann, Donna, Alison Cooper, Kate Grimshaw, et al.. (2007). Food additives and hyperactive behaviour in 3-year-old and 8/9-year-old children in the community: a randomised, double-blinded, placebo-controlled trial. The Lancet. 370(9598). 1560–1567. 784 indexed citations breakdown →
7.
Cooper, Alison, et al.. (2007). Secondary prevention for patients after a myocardial infarction: summary of NICE guidance. BMJ. 334(7603). 1112–1113. 20 indexed citations
8.
Skinner, Jane, Alison Cooper, & Gene Feder. (2007). Secondary prevention for patients following a myocardial infarction: summary of NICE guidance. Heart. 93(7). 862–864. 26 indexed citations
9.
Lloyd, Guy, et al.. (2000). ARE WOMEN DISCRIMINATED AGAINST FOR LIPID LOWERING THERAPY? RESULTS FROM A PROSPECTIVE COHORT OF WOMEN WITH CORONARY ARTERY DISEASE. International Journal of Clinical Practice. 54(4). 217–219. 1 indexed citations
10.
Lloyd, Guy, et al.. (2000). A randomised placebo controlled trial of the effects of tibolone on blood pressure and lipids in hypertensive women. Journal of Human Hypertension. 14(2). 99–104. 35 indexed citations
12.
Crook, David, et al.. (1999). A randomised comparison of the effects of oral versus transdermal 17β‐oestradiol, each combined with sequential oral norethisterone acetate, on serum lipoprotein levels. BJOG An International Journal of Obstetrics & Gynaecology. 106(9). 948–953. 24 indexed citations
13.
Mitchell, Ian, Alison Cooper, Mark Griffiths, & David J. Barber. (1998). Phencyclidine and corticosteroids induce apoptosis of a subpopulation of striatal neurons: A neural substrate for psychosis?. Neuroscience. 84(2). 489–501. 56 indexed citations
14.
Peipert, J., et al.. (1997). Endovaginal sonography for the diagnosis of upper genital tract infection. Obstetrics and Gynecology. 90(1). 54–57. 38 indexed citations
15.
Ross, David J., et al.. (1997). Endometrial effects of three doses of trimegestone, a new orally active progestogen, on the postmenopausal endometrium. Maturitas. 28(1). 83–88. 4 indexed citations
16.
Cooper, Alison, et al.. (1997). Fortnightly review: Management of abnormal bleeding in women receiving hormone replacement therapy. BMJ. 315(7099). 37–42. 15 indexed citations
17.
Tempe, Deepak K., Alison Cooper, Sangeeta Khanna, et al.. (1996). Blood conservation in small adults undergoing valve surgery. Journal of Cardiothoracic and Vascular Anesthesia. 10(4). 502–506. 21 indexed citations
19.
Mitchell, Ian, Alison Cooper, Gordon D. A. Brown, & Catherine Waters. (1995). Apoptosis of neurons in the vestibular nuclei of adult mice results from prolonged change in the external environment. Neuroscience Letters. 198(3). 153–156. 3 indexed citations
20.
Brotchie, Jonathan M., Alan R. Crossman, Ian Mitchell, et al.. (1993). Chapter 8 Chemical signalling in the globus pallidus in parkinsonism. Progress in brain research. 99. 125–139. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026